Malnutrition: laboratory markers vs nutritional assessment.

Bharadwaj S, Ginoya S, Tandon P, Gohel TD, Guirguis J, Vallabh H, Jevenn A, Hanouneh I. · 2016

Read Malnutrition: laboratory markers vs nutritional assessment. by Bharadwaj S, Ginoya S, Tandon P, Gohel TD, Guirguis J, Vallabh H, Jevenn A, Hanouneh I. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5193064.txt.

Introduction

Shishira Bharadwaj and seven co-authors ask how malnutrition should actually be diagnosed. The condition raises illness, death, and hospital costs, yet it lacks a single agreed definition. Reported prevalence runs from 30 to 50 percent of patients, and as high as 85 percent in long-term care. Doctors have long leaned on serum proteins such as albumin and prealbumin. The review finds those markers unreliable on their own, because inflammation distorts them.

The authors give the central role to a nutrition-focused physical examination. Lab values can support that examination but cannot replace it. They estimate the malnutrition tied to eight major diseases costs about 157 billion dollars, and malnourished patients stay in hospital about 11 days longer. Future work, they argue, should hunt for blood biomarkers that inflammation does not disturb.

Catalog record

CREATORBharadwaj S, Ginoya S, Tandon P, Gohel TD, Guirguis J, Vallabh H, Jevenn A, Hanouneh I.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5193064

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Malnutrition: laboratory markers vs nutritional assessment By Shishira Bharadwaj, Shaiva Ginoya, Parul Tandon, Tushar D Gohel, John Guirguis, Hiren Vallabh, Andrea Jevenn, Ibrahim Hanouneh Published in: Gastroenterology Report DOI: 10.1093/gastro/gow013 ABSTRACT Abstract Malnutrition is an independent risk factor for patient morbidity and mortality and is associated with increased healthcare-related costs. However, a major dilemma exists due to lack of a unified definition for the term. Furthermore, there are no standard methods for screening and diagnosing patients with malnutrition, leading to confusion and varying practices among physicians across the world. The role of inflammation as a risk factor for malnutrition has also been recently recognized. Historically, serum proteins such as albumin and prealbumin (PAB) have been widely used by physicians to determine patient nutritional status. However, recent focus has been on an appropriate nutrition-focused physical examination (NFPE) for diagnosing malnutrition. The current consensus is that laboratory markers are not reliable by themselves but could be used as a complement to a thorough physical examination. Future studies are needed to identify serum biomarkers in order to diagnose malnutrition unaffected by inflammatory states and have the advantage of being noninvasive and relatively cost-effective. However, a thorough NFPE has an unprecedented role in diagnosing malnutrition. Keywords: malnutrition, physical examination, serum markers INTRODUCTION Malnutrition presents a substantial socioeconomic challenge in today’s healthcare landscape with an estimated prevalence of 30–50% [1–7]. The prevalence may be even higher in long-term care facilities, where it has been reported to be as high as 85% [1–7]. However, due to historical inconsistencies in defining and identifying malnutrition, the actual prevalence in the population is unknown [8]. Furthermore, malnutrition has been associated with increased healthcare-associated costs including longer hospital length of stay (LOS) and increased rates of major and minor complications [9]. Looking at just eight diseases (chronic obstructive pulmonary disease [COPD], coronary artery disease, breast cancer, colorectal cancer, depression, dementia, stroke, and musculoskeletal disorders), the economic burden of their associated malnutrition has been estimated to be around US $157 billion, with COPD having the highest economic burden out of those [10]. Additionally, malnourished patients have a longer LOS at healthcare facilities by an average of 11 days. Moreover, they were found to have higher rates of readmission or require ongoing services such as home healthcare following discharge [11]. Hence, due to the recognition of the importance of the impact of malnutrition on economic burden, the Centers for Medicare and Medicaid Services (CMS) have implemented a change in their reimbursement rates according to its severity [5]. Malnutrition is associated with an increased risk of major and minor complications as well as an increase in direct and indirect costs. One retrospective study of 709 adult patients from 25 Brazilian hospitals reported that the incidence of complications in the malnourished was 27% (relative risk [RR] = 1.60) compared with17% in the well-nourished counterparts [12]. Furthermore, mortality in the malnourished patients was 12.4% vs 4.7% in the well-nourished patients (RR = 2.63). Similarly, another study of 104 patients with acute stroke of < 24 hours duration reported that malnourished patients were more likely to have higher stress reaction, increased frequency of infections and pressure ulcers compared with the appropriately nourished group [13]. Additionally, disease-associated malnutrition results in an increased number of missed days from work and therefore lower economic productivity [14]. Indirect costs related to care provided by family members and the subsequent effect on their socioeconomic activities cannot be accurately determined [10]. Nevertheless, the impact of malnutrition on our society is substantial, and accurate diagnostic measures are necessary to identify those at risk. A major obstacle for diagnosing malnutrition is the lack of a unified definition of the term. Furthermore, there is no standard method for screening and diagnosing patients with malnutrition, leading to confusion and varying practices among physicians across the world. The appreciation that inflammation plays a major role in the pathophysiology of malnutrition is also lacking. Overall, this has led to a lot of misdiagnoses and a general under-recognition of the importance of malnutrition [2]. An all-encompassing definition of malnutrition has been proposed by Jenson et al. as “decline in lean body mass with the potential for functional impairment” [1]. This impairment can be at different levels of function ranging from molecular to gross motor. They also realized the role of inflammation leading to either acute or chronic disease-related malnutrition. Non-inflammatory states such as chronic starvation and anorexia nervosa are also recognized as separate categories of malnutrition [1]. There are a number of tools that are used to assess the characteristics of malnutrition. This paper will focus on two of the frequently used malnutrition assessment tools—laboratory data (serum markers) and physical examination (nutritional assessment)—and compare them to assess which is more useful in a clinical setting. LABORATORY/SERUM MARKERS Historically, serum proteins such as albumin and prealbumin (i.e. transthyretin) have been widely used by physicians to determine patients’ nutritional status (Figure 1). Other markers that have been studied include retinol-binding protein (RBP), transferrin, total cholesterol and indicators of inflammation such as C-reactive protein (CRP) and total lymphocyte count (TLC). These markers and their role in assessing malnutrition will be discussed in this section. [Figure: Laboratory markers] Albumin Albumin is a serum hepatic protein with a half-life of 14–20 days. It functions as a carrier molecule for various minerals, hormones and fatty acids and also helps to maintain oncotic pressure in the capillaries [15]. More than 50% of its total pool is located in the extravascular compartment, and only a minority of it (about 5%) is produced by the liver daily. Thus, a patient’s protein consumption in a day has hardly any effect on the patient’s albumin level [16]. However, albumin is characterized as a negative acute-phase protein, and its pool is affected by a number of inflammatory conditions and drugs, especially those that affect liver function. For example, hepatic failure, burns, sepsis, trauma, post-surgery states and cancer have all been shown to decrease albumin levels. The concept of “stress-induced hypoalbuminemia” is somewhat controversial, but it demonstrates the concept of the body’s normal physiological response to injury. Since there are a multitude of disease processes that alter the level of albumin, it becomes an unreliable serum marker for malnutrition. This is especially true in acute healthcare settings, where a number of infectious and inflammatory states alter the serum concentration of albumin. Despite this, physicians frequently rely on albumin levels to gauge a patient’s nutritional status. However, there is some contrary evidence that measuring albumin levels may be a useful tool for diagnosing malnutrition, especially in cardiac transplant and orthopedic patients. In one study of 60 cardiac transplant recipients at least five years post transplant, serum albumin was found to be a better predictor of underlying malnutrition than body mass index (BMI) and subjective global assessment (SGA) [17]. Similarly, serum albumin has also been used during preoperative management to screen and treat at-risk patients undergoing elective orthopedic surgery to reduce postoperative complications [18]. The evidence is weak for using serum albumin as a marker of malnutrition in non-inflammatory states such as starvation. A meta-analysis of 63 studies, which included 2125 patients and investigated the effects of starvation on serum albumin levels in otherwise healthy individuals, reported that the levels remained normal until the

Read the complete text